Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. (COLY) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 26 transactions totaling $2.0M, demonstrating a bullish sentiment with $1.3M in net insider flow. The most recent transaction on Jan 4, 2008 involved a transaction of 135,783 shares valued at $0.
COLY Insider Activity Summary
Who Is Buying COLY Stock?
No significant insider buying has been recorded for COLY in the recent period.
Who Is Selling COLY Stock?
No significant insider selling has been recorded for COLY in the recent period.
Is Coley Pharmaceutical Group, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for COLY is bullish with an Insider Alignment Score of 84/100 and a net flow of $1.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
COLY Frequently Asked Questions
Understanding COLY Insider Activity
Insider trading at Coley Pharmaceutical Group, Inc. (COLY) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading COLY stock, having executed 26 transactions in the past 90 days. The most active insider is James E. Thomas (Executive), who has made 5 transactions totaling $1.4M.
Related Tools
Track Coley Pharmaceutical Group, Inc. Insider Activity
Get notified when executives and directors at COLY file new Form 4 transactions